These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


259 related items for PubMed ID: 2472362

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Procainamide, N-acetylprocainamide, antinuclear antibody and systemic lupus erythematosus.
    Reidenberg MM, Drayer DE.
    Angiology; 1986 Dec; 37(12 Pt 2):968-71. PubMed ID: 2433971
    [Abstract] [Full Text] [Related]

  • 26. [New anti-arrhythmia drug. III. Comparative studies of the effects of N-propionylprocainamide, procainamide and N-acetylprocainamide on hemodynamics and cardiac blood flow].
    Kusowska J, Polakowski P.
    Acta Pol Pharm; 1989 Dec; 46(2):187-94. PubMed ID: 2483600
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of very rapid emit Qst methods for measuring serum procainamide and N-acetylprocainamide concentrations.
    Carnes CA, Coyle JD.
    Pharmacotherapy; 1992 Dec; 12(1):40-4. PubMed ID: 1372425
    [Abstract] [Full Text] [Related]

  • 28. [Simultaneous predictions of disposition kinetics of procainamide and its metabolite N-acetylprocainamide in rat by a physiological pharmacokinetic model].
    Liu XD, Deng N, Huang SK.
    Yao Xue Xue Bao; 1991 Dec; 26(10):725-32. PubMed ID: 1726674
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pharmacokinetics of N-acetylprocainamide in patients profiled with a stable isotope method.
    Atkinson AJ, Ruo TI, Piergies AA, Breiter HC, Connelly TJ, Sedek GS, Juan D, Hubler GL, Hsieh AM.
    Clin Pharmacol Ther; 1989 Aug; 46(2):182-9. PubMed ID: 2474402
    [Abstract] [Full Text] [Related]

  • 31. Intravenous N-acetylprocainamide disposition kinetics in coronary artery disease.
    Kates RE, Jaillon P, Rubenson DS, Winkle RA.
    Clin Pharmacol Ther; 1980 Jul; 28(1):52-7. PubMed ID: 6156049
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics of N-acetylprocainamide.
    Atkinson AJ, Ruo TI.
    Angiology; 1986 Dec; 37(12 Pt 2):959-67. PubMed ID: 2433970
    [Abstract] [Full Text] [Related]

  • 36. Circadian changes in procainamide and N-acetylprocainamide kinetics in the rat.
    Bruguerolle B, Jadot G.
    J Pharm Pharmacol; 1985 Sep; 37(9):654-6. PubMed ID: 2416904
    [Abstract] [Full Text] [Related]

  • 37. [A new anti-arrhythmia drug. II. Comparative studies of the effects of a new acyl derivative of procainamide, procainamide and N-acetylprocainamide on blood pressure and the electrocardiogram in rabbits].
    Kusowska J.
    Acta Pol Pharm; 1989 Sep; 46(1):90-7. PubMed ID: 2479226
    [Abstract] [Full Text] [Related]

  • 38. Effect kinetics of N-acetylprocainamide-induced QT interval prolongation.
    Piergies AA, Ruo TI, Jansyn EM, Belknap SM, Atkinson AJ.
    Clin Pharmacol Ther; 1987 Jul; 42(1):107-12. PubMed ID: 2439251
    [Abstract] [Full Text] [Related]

  • 39. Electrophysiologic properties and antiarrhythmic mechanisms of intravenous N-acetylprocainamide in patients with ventricular dysrhythmias.
    Sung RJ, Juma Z, Saksena S.
    Am Heart J; 1983 May; 105(5):811-9. PubMed ID: 6189384
    [Abstract] [Full Text] [Related]

  • 40. Kinetics of procainamide and N-acetylprocainamide in renal failure.
    Gibson TP, Atkinson AJ, Matusik E, Nelson LD, Briggs WA.
    Kidney Int; 1977 Dec; 12(6):422-9. PubMed ID: 609192
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.